These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24604742)

  • 21. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.
    Ito S; Ohtsuki S; Kamiie J; Nezu Y; Terasaki T
    J Neurochem; 2007 Dec; 103(6):2482-90. PubMed ID: 17908238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E and central nervous system disorders: reviews of clinical findings.
    Takeda M; Martínez R; Kudo T; Tanaka T; Okochi M; Tagami S; Morihara T; Hashimoto R; Cacabelos R
    Psychiatry Clin Neurosci; 2010 Dec; 64(6):592-607. PubMed ID: 21105952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.
    Hyman BT; Strickland D; Rebeck GW
    Arch Neurol; 2000 May; 57(5):646-50. PubMed ID: 10815129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [How ApoE regulates blood-brain barrier integrity].
    Gosselet F
    Med Sci (Paris); 2012 Nov; 28(11):920-3. PubMed ID: 23171891
    [No Abstract]   [Full Text] [Related]  

  • 26. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.
    Chen Y; Strickland MR; Soranno A; Holtzman DM
    Neuron; 2021 Jan; 109(2):205-221. PubMed ID: 33176118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sortilin, a novel APOE receptor implicated in Alzheimer disease.
    Carlo AS
    Prion; 2013; 7(5):378-82. PubMed ID: 24121631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease.
    Mancini S; Minniti S; Gregori M; Sancini G; Cagnotto A; Couraud PO; Ordóñez-Gutiérrez L; Wandosell F; Salmona M; Re F
    Nanomedicine; 2016 Jan; 12(1):43-52. PubMed ID: 26410276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.
    Lane-Donovan C; Herz J
    Trends Endocrinol Metab; 2017 Apr; 28(4):273-284. PubMed ID: 28057414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.
    Bu G
    Nat Rev Neurosci; 2009 May; 10(5):333-44. PubMed ID: 19339974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol homeostasis in neurons and glial cells.
    Vance JE; Hayashi H; Karten B
    Semin Cell Dev Biol; 2005 Apr; 16(2):193-212. PubMed ID: 15797830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulated proteolysis of APP and ApoE receptors.
    Hoe HS; Rebeck GW
    Mol Neurobiol; 2008 Feb; 37(1):64-72. PubMed ID: 18415033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipids in Amyloid-β Processing, Aggregation, and Toxicity.
    Morgado I; Garvey M
    Adv Exp Med Biol; 2015; 855():67-94. PubMed ID: 26149926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.
    Shinohara M; Tachibana M; Kanekiyo T; Bu G
    J Lipid Res; 2017 Jul; 58(7):1267-1281. PubMed ID: 28381441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.
    Chernick D; Ortiz-Valle S; Jeong A; Qu W; Li L
    Neurosci Lett; 2019 Aug; 708():134306. PubMed ID: 31181302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.
    Casey CS; Atagi Y; Yamazaki Y; Shinohara M; Tachibana M; Fu Y; Bu G; Kanekiyo T
    J Biol Chem; 2015 May; 290(22):14208-17. PubMed ID: 25903128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imbalanced cholesterol metabolism in Alzheimer's disease.
    Xue-Shan Z; Juan P; Qi W; Zhong R; Li-Hong P; Zhi-Han T; Zhi-Sheng J; Gui-Xue W; Lu-Shan L
    Clin Chim Acta; 2016 May; 456():107-114. PubMed ID: 26944571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New gene tied to common form of Alzheimer's.
    Marx J
    Science; 1998 Jul; 281(5376):507, 509. PubMed ID: 9705719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.